Detalhe da pesquisa
1.
Upstream Position of Proline Defines Peptide-HLA Class I Repertoire Formation and CD8+ T Cell Responses.
J Immunol
; 202(10): 2849-2855, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30936292
2.
Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells.
Eur J Immunol
; 46(4): 929-40, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26711740
3.
Hypoxia augments MHC class I antigen presentation via facilitation of ERO1-α-mediated oxidative folding in murine tumor cells.
Eur J Immunol
; 46(12): 2842-2851, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27667124
4.
Immune responses to human cancer stem-like cells/cancer-initiating cells.
Cancer Sci
; 107(1): 12-7, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26440127
5.
Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level.
Br J Cancer
; 114(11): 1227-34, 2016 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27100727
6.
Interphase phosphorylation of lamin A.
J Cell Sci
; 127(Pt 12): 2683-96, 2014 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24741066
7.
A novel nuclear DnaJ protein, DNAJC8, can suppress the formation of spinocerebellar ataxia 3 polyglutamine aggregation in a J-domain independent manner.
Biochem Biophys Res Commun
; 474(4): 626-633, 2016 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27133716
8.
Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.
J Biol Chem
; 289(32): 22035-47, 2014 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24962571
9.
Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells.
Cancer Sci
; 105(4): 389-95, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24450541
10.
Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population.
Exp Mol Pathol
; 92(1): 27-32, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22001602
11.
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes.
Cell Rep
; 38(5): 110331, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108529
12.
CD8+ T-cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1.
Cancer Immunol Res
; 9(11): 1342-1353, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433589
13.
ï¼Editors' Choiceï¼ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity.
Nagoya J Med Sci
; 81(1): 1-18, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962651
14.
Providing cellular signposts--post-translational modifications of intermediate filaments.
FEBS Lett
; 582(14): 2140-8, 2008 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-18502206
15.
The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer.
Cancer Immunol Res
; 6(3): 358-369, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371260
16.
Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer.
Oncotarget
; 8(15): 24706-24718, 2017 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28160557
17.
HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses.
Oncoimmunology
; 6(4): e1293214, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533942
18.
Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition.
Oncoimmunology
; 6(2): e1274476, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28344889
19.
Phosphorylation of lamins determine their structural properties and signaling functions.
Nucleus
; 6(3): 166-71, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25793944
20.
HLA class I as a predictor of clinical prognosis and CTL infiltration as a predictor of chemosensitivity in ovarian cancer.
Oncoimmunology
; 4(5): e1005507, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26155404